SARS-CoV (902-947)[K2N,I4S,N9Q,A11E,Q16N,S18V,S23N,A25S,V32D,A37N,A39S,V44Q,Q46E]
General Information
DRACP ID DRACP03992
Peptide Name SARS-CoV (902-947)[K2N,I4S,N9Q,A11E,Q16N,S18V,S23N,A25S,V32D,A37N,A39S,V44Q,Q46E]
Sequence QNQSANQFQKEISQINEVLTTTNTSLGKLQDDVNQNNQSLNTLQKE
Sequence Length 46
UniProt ID P59594
PubChem CID Not available
Origin Synthetic
Type Synthetic peptide
Classification
Active ACP
Activity Information
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity Not available
Target Not available
Affinity Not available
Mechanism Not available
Nature Anticancer; Antiviral
Structure Information
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Free
Other Modification None
Chiral L
Physicochemical Information
Formula C216H356N66O83
Absent amino acids CHMPRWY
Common amino acids Q
Mass 600845
Pl 4.26
Basic residues 3
Acidic residues 5
Hydrophobic residues 11
Net charge -2
Boman Index -13570
Hydrophobicity -119.13
Aliphatic Index 74.13
Half Life
Mammalian: 0.8 hour
Yeast: 10 min
E.coli: >10 hour
Extinction Coefficient cystines 0
Absorbance 280nm 0
Polar residues 18
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 18983873
Title Identification of a minimal peptide derived from heptad repeat (HR) 2 of spike protein of SARS-CoV and combination of HR1-derived peptides as fusion inhibitors
Doi Not available
Year 2009
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available
External Code
DBAASP ID 15210